Goodwin Procter and Wilson Sonsini Goodrich & Rosati represented MBX Biosciences, Inc. in the offering, and Davis Polk & Wardwell represented the underwriters.MBX Biosciences, Inc. (Nasdaq:…
- Homepage
- North America
- North America Legal Chronicle
- MBX Biosciences’ $187.7 Million IPO
MBX Biosciences’ $187.7 Million IPO
Tagged: 9-23-2024 AJ Stautz Alanna Phillips Alastair Papworth Alexandra Haas Arisa Sin Austin Church Benjamin Kurrass Brian Mukherjee Caroline Bullerjahn Cecelia Lockner Christina Lewis Daniel Hughes David Bauer David Beer Davis Polk & Wardwell Duncan Greenhalgh Edwin O'Connor Eric Graffeo Ettore Santucci Eunice Chang Ginggi Storer Goodwin Procter Guggenheim Securities Heath Ingram J.P. Morgan Securities LLC Jacob Lee Jacqueline Klosek James Matarese Janet Andolina Jefferies Finance LLC Jennifer Burns Luz Jenny Li Jo-an Chen Jordan Khorshad Julie Tibbets Justine Park Kathryn Clerici Kimberly Hickey Li Chang Lily Xu Lucy Sharples Luke Nauth Marcie Goldstein Marco Wong Mario Verdolini MBX Biosciences Inc. Michael Hostetler Mitchell Bloom Nima Zargari Richard Truesdell Jr. Ryan Donahoe Sarah Bock Stifel, Nicolaus & Company, Incorporated Tim Worden Tyler Mayo Uale Taotafa Wilson Sonsini Goodrich & Rosati
Author: Leila Ahmed
…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here